Myocarditis and Pericarditis Post-mRNA COVID-19 Vaccination: Insights from a Pharmacovigilance Perspective

Concerns remain regarding the rare cardiovascular adverse events, myocarditis and pericarditis (myo/pericarditis), particularly in younger individuals following mRNA COVID-19 vaccination. Our study aimed to comprehensively assess potential safety signals related to these cardiac events following the...

Descripción completa

Detalles Bibliográficos
Autores principales: Alami, Abdallah, Villeneuve, Paul J., Farrell, Patrick J., Mattison, Donald, Farhat, Nawal, Haddad, Nisrine, Wilson, Kumanan, Gravel, Christopher A., Crispo, James A. G., Perez-Lloret, Santiago, Krewski, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10419493/
https://www.ncbi.nlm.nih.gov/pubmed/37568373
http://dx.doi.org/10.3390/jcm12154971

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10419493/
https://www.ncbi.nlm.nih.gov/pubmed/37568373
http://dx.doi.org/10.3390/jcm12154971

Ejemplares similares